Literature DB >> 19145655

Case of acute motor conduction block neuropathy (AMCBN).

Fiore Manganelli1, Chiara Pisciotta, Rosa Iodice, Sara Calandro, Raffaele Dubbioso, Angelo Ranieri, Lucio Santoro.   

Abstract

We describe a 21 year-old man with an acute development of weakness whose clinical and serial electrophysiological findings were atypical for Guillain-Barré syndrome. Electrophysiological data suggested a diagnosis of "acute motor conduction block neuropathy" (AMCBN). The 6 months of disease duration and the electrophysiological follow-up, which never showed axonal degeneration until complete clinical recovery, raise the issue of the relationship between AMCBN and acute motor axonal neuropathy (AMAN).

Entities:  

Mesh:

Year:  2009        PMID: 19145655     DOI: 10.1002/mus.21219

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  4 in total

1.  Serial electrophysiological findings in Guillain-Barré syndrome not fulfilling AIDP or AMAN criteria.

Authors:  Takafumi Hosokawa; Hideto Nakajima; Kiichi Unoda; Kazushi Yamane; Yoshimitsu Doi; Shimon Ishida; Fumiharu Kimura; Toshiaki Hanafusa
Journal:  J Neurol       Date:  2016-06-08       Impact factor: 4.849

2.  Acute Motor Conduction Block Neuropathy: Another Distinct Variant of Guillain-Barre Syndrome.

Authors:  Nilüfer Erdoğmuş Ince; M Fevzi Öztekin; Neşe Öztekin
Journal:  Noro Psikiyatr Ars       Date:  2014-03-01       Impact factor: 1.339

3.  Acute Motor Axonal Neuropathy (Aman) With Motor Conduction Blocks In Childhood; Case Report.

Authors:  Serhan Yildirim; Rahşan Adviye; Hakan Levent Gül; Ülkü Türk Börü
Journal:  Iran J Child Neurol       Date:  2016

4.  Miller Fisher syndrome, Bickerstaff brainstem encephalitis and Guillain-Barré syndrome overlap with persistent non-demyelinating conduction blocks: a case report.

Authors:  Angela Puma; Jeanne Benoit; Sabrina Sacconi; Antonino Uncini
Journal:  BMC Neurol       Date:  2018-07-21       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.